05:00:08 EST Wed 01 Dec 2021
Enter Symbol
or Name

Login ID:
Aurora Cannabis Inc (2)
Symbol ACB
Shares Issued 116,320,703
Close 2020-11-10 C$ 10.78
Recent Sedar Documents

Aurora Cannabis looks to raise $125-million (U.S.)

2020-11-10 17:29 ET - News Release

Ms. Michelle Lefler reports


Aurora Cannabis Inc. will be filing a preliminary prospectus supplement to its short form base shelf prospectus dated Oct. 28, 2020, relating to a proposed overnight marketed public offering of units of the company at a price of $7.50 (U.S.) per unit for total gross proceeds to the company of approximately $125-million (U.S.).

Each unit will comprise one common share of the company and one-half of one common share purchase warrant of the company (each full common share purchase warrant). Each warrant will be exercisable to acquire one common share of the company for a period of 40 months following the closing date of the offering at an exercise price of $9.00 (U.S.) per warrant share, subject to adjustment in certain events.

The final terms of the offering are to be determined at the time of pricing. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The closing of the offering will be subject to market and other customary conditions, including approvals of the Toronto Stock Exchange and the New York Stock Exchange.

In addition, the company intends to grant the underwriters a 30-day option to purchase up to an additional 15 per cent of the units offered in the proposed offering on the same terms and conditions. This option may be exercised by the underwriters for additional units, common shares, warrants or any combination of such securities.

The company expects to use the net proceeds from the offering, if any, to finance growth opportunities, working capital and other general corporate purposes.

BMO Capital Markets and ATB Capital Markets are acting as the bookrunners for the offering.

The preliminary supplement will be filed with the securities commissions or similar securities regulatory authorities in each of the provinces of Canada, except Quebec, and with the U.S. Securities and Exchange Commission (SEC) as part of the company's registration statement on Form F-10 under the U.S./Canada Multijurisdictional Disclosure System. The preliminary supplement, the base shelf prospectus and the registration statement contain important detailed information about the company and the proposed offering. Prospective investors should read the preliminary supplement, the base shelf prospectus and the registration statement and the other documents the company has filed for more complete information about the company and this offering before making an investment decision.

Copies of the preliminary supplement, following filing thereof, and the base shelf prospectus will be available on SEDAR and copies of the preliminary supplement and the registration statement will be available on EDGAR. Copies of the preliminary supplement, following filing thereof, the base shelf prospectus and the registration statement may also be obtained from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Centre c/o The Data Group of Companies, 9195 Torbram Rd., Brampton, Ont., L6S 6H2, or by telephone at 905-791-3151, extension 431, or by e-mail at torbramwarehouse@datagroup.ca, or from BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, N.Y., 10036, USA (Attn: Equity Syndicate), or by telephone at 800-414-3627, or by e-mail at bmoprospectus@bmo.com. Copies of such documents may also be obtained from ATB Capital Markets Inc., Attn: Gail O'Connor, 410-585 8th Ave. SW, Calgary, Alta., T2P 1G1, 403-539-8629, or by e-mail from atbcm_dealflow@atb.com.

About Aurora Cannabis Inc.

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva. Providing customers with innovative, high-quality cannabis and hemp products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.